Health PCSK9 Inhibitors & Lower LDL Targets for High-Risk Diabetics: VESALIUS-CV Trial by Grace Chen March 29, 2026 written by Grace Chen March 29, 2026 69 Related 0 comments 0 FacebookTwitterPinterestEmail Grace Chen Board-certified physician and medical writer. Translates research into practical health advice and public-health coverage. previous post Hand, Foot, and Mouth Disease: Symptoms & What Parents Need to Know next post Pakistan, Turkey, Egypt & Saudi Arabia Seek to End US-Israel War on Iran You may also like Statin Users Can Lower Cholesterol Further With This... September 2, 2026 NHS A&E Mental Health Visits for Children Up... September 2, 2026 Rett Syndrome Breathing Issues Linked to Peripheral Chemoreceptors September 2, 2026 Congo Ebola Outbreak Surpasses 3,000 Deaths as Virus... September 2, 2026 Flesh-Eating Fly Detected in Mexico Just 31 Miles... September 2, 2026 UK pledges over £50 million to fight Congo’s... September 2, 2026 Dementia Diagnosis: Campaigners Urge UK Government to Cut... September 2, 2026 NC Teen Dies After Contracting Rare Brain-Eating Amoeba... September 2, 2026 POET-II Trial: Tailored Antibiotics Shorten Endocarditis Treatment by... September 2, 2026 EFHD1 Protein Blockade Reduces Liver Damage and Inflammation... September 1, 2026 Leave a Comment Cancel Reply Notify me of follow-up comments by email. Notify me of new posts by email. Δ
